Open Access

EDITORIAL The International Journal of Oncology: 30 years of progress (1992-2021)

  • Authors:
    • Demetrios A. Spandidos
  • View Affiliations

  • Published online on: May 7, 2021     https://doi.org/10.3892/ijo.2021.5216
  • Article Number: 36
  • Copyright: © Spandidos . This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We are hereby very pleased to announce that the International Journal of Oncology is now celebrating its 30th year of publication since the inaugural issue in 1992. During this time span of three decades, the journal has had the pleasure of publishing a variety of research articles and reviews submitted by authors from around the world, thus bringing to light new insight into the field of oncology. The International Journal of Oncology has always aimed to publish high quality research on oncology from a diversity of international contributors. This diversity is depicted in Table I below, which presents the list of countries from which the articles have originated over the years. We would also like to take this opportunity to thank all the authors and reviewers who have contributed to the success of the journal over the years, and with their support, we look forward to an even brighter future.


International Journal of Oncology (1992-June 2021).

Country No. of articles (% total)
1. USA 2,514 (22.7)
2. Japan 2,421 (21.9)
3. P.R. China 1,061 (9.6)
4. Germany 854 (7.7)
5. Italy 669 (6.0)
6. South Korea 533 (4.8)
7. UK 437 (3.9)
8. France 317 (2.9)
9. Sweden 288 (2.6)
10. Canada 202 (1.8)
11. Spain 123
12. Belgium 110
13. Taiwan R.O.C 109
14. Austria 95
15. Czech Republic 94
16. Switzerland 91
17. Greece 85
18. The Netherlands 85
19. Poland 79
20. Singapore 74
21. Israel 72
22. Norway 71
23. Australia 68
24. Hong Kong 56
25. Denmark 52
26. India 43
27. Brazil 40
28. Finland 34
29. Argentina 28
30. Chile 26
31. Mexico 23
32. Egypt 22
33. Hungary 22
34. Thailand 22
35. Saudi Arabia 20
36. Ireland 19
37. South Africa 19
38. Russia 17
39. Slovak Republic 15
40. Lebanon 11
41. Croatia 9
42. Turkey 9
43. Kuwait 8
44. Malaysia 8
45. Portugal 8
46. Indonesia 7
47. Luxembourg 6
48. Tunisia 6
49. Estonia 5
50. Guatemala 5
51. Iceland 5
52. New Zealand 5
53. Romania 5
54. Slovenia 5
55. United Arab Emirates 5
56. Vietnam 5
57. Uruguay 4
58. Pakistan 3
59. Philippines 3
60. Cuba 2
61. Cyprus 2
62. Ethiopia 2
63. Guadeloupe 2
64. Iran 2
65. Lithuania 2
66. Qatar 2
67. Serbia 2
68. Syria 2
69. Tanzania 2
70. Ukraine 2
71. Venezouela 2
72. Armenia 1
73. Belarus 1
74. Burkina Faso 1
75. Colombia 1
76. Honduras 1
77. Iraq 1
78. Libya 1
79. Martinique 1
80. Morocco 1
81. Republic of Cameroon 1
82. Tajikistan 1
83. Yemen 1
Totala 11,070

aSome articles were published jointly with scientists from more than one country. The actual total number of articles is 9,331.


The most frequently cited publications are presented.

  PUBLICATIONS   CITATIONS
1. THE ANTI-MALARIAL ARTESUNATE IS ALSO ACTIVE AGAINST CANCER   508
  By: EFFERTH T, DUNSTAN H, SAUERBREY A, et al Int J Oncol 18: 767-773, 2001  
2. A NEW FLUOROMETRIC ASSAY FOR CYTOTOXICITY MEASUREMENTS IN VITRO   502
  By: PAGE B, PAGE M, NOEL C Int J Oncol 3: 473-476, 1993  
3. TEA IN CHEMOPREVENTION OF CANCER: EPIDEMIOLOGIC AND EXPERIMENTAL STUDIES (REVIEW)   412
  By: KATIYAR SK, MUKHTAR H Int J Oncol 8: 221-238, 1996  
4. HUMAN FOX GENE FAMILY (REVIEW)   402
  By: KATOH M, KATOH M Int J Oncol 25: 1495-1500, 2004  
5. APIGENIN AND CANCER CHEMOPREVENTION: PROGRESS, POTENTIAL AND PROMISE (REVIEW)   380
  By: PATEL D, SHUKLA S, GUPTA S Int J Oncol 30: 233-245, 2007  
6. REGULATION OF CELL CYCLE PROGRESSION AND APOPTOSIS BY THE Ras/Raf/MEK/ERK PATHWAY (REVIEW)   341
  By: CHANG FM, STEELMAN LS, SHELTON JG, et al Int J Oncol 22: 469-480, 2003  
7. CHEMORESISTANCE TO PACLITAXEL INDUCES EPITHELIAL-MESENCHYMAL TRANSITION AND ENHANCES METASTATIC POTENTIAL FOR EPITHELIAL OVARIAN CARCINOMA CELLS   332
  By: KAJIYAMA H, SHIBATA K, TERAUCHI M, et al Int J Oncol 31: 277-283, 2007  
8. OVER- AND UNDER-EXPRESSED microRNAs IN HUMAN COLORECTAL CANCER   306
  By: MOTOYAMA K, INOUE H, TAKATSUNO Y, et al Int J Oncol 34: 1069-1075, 2009  
9. CANCER CHEMOPREVENTION BY RESVERATROL: IN VITRO AND IN VIVO STUDIES AND THE UNDERLYING MECHANISMS (REVIEW)   284
  By: AZIZ MH, KUMAR R, AHMAD N Int J Oncol 23: 17-28, 2003  
10. INDUCTION OF CELL CYCLE ARREST AND APOPTOSIS IN HUMAN BREAST CANCER CELLS BY QUERCETIN   284
  By: CHOI JA, KIM JY, LEE JY, et al Int J Oncol 19: 837-844, 2001  
11. ANTIPROLIFERATIVE EFFECT OF SYNTHETIC RESVERATROL ON HUMAN BREAST EPITHELIAL CELLS   279
  By: MGBONYEBI OP, RUSSO J, RUSSO IH Int J Oncol 12: 865-869, 1998  
12. MALAT-1: A LONG NON-CODING RNA AND ITS IMPORTANT 3’ END FUNCTIONAL MOTIF IN COLORECTAL CANCER METASTASIS   277
  By: XU C, YANG M, TIAN J, et al Int J Oncol 39: 169-175, 2011  
13. CELL DEATH: APOPTOSIS VERSUS NECROSIS (REVIEW)   267
  By: KANDUC D, MITTELMAN A, SERPICO R, et al Int J Oncol 21: 165-170, 2002  
14. DNA STRAND BREAKS OCCURRING DURING APOPTOSIS - THEIR EARLY IN SITU DETECTION BY THE TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE AND NICK TRANSLATION ASSAYS AND PREVENTION BY SERINE PROTEASE INHIBITORS   263
  By: GORCZYCA W, BRUNO S, DARZYNKIEWICZ RJ, et al Int J Oncol 1: 639-648, 1992  
15. FLAVOPIRIDOL (L86 8275; NSC 649890), A NEW KINASE INHIBITOR FOR TUMOR THERAPY   254
  By: SEDLACEK HH, CZECH J, NAIK R, et al Int J Oncol 9: 1143-1168, 1996  
16. EXPRESSION AND EPITHELIAL CELL ADHESION MOLECULE IN CARCINOMA CELLS PRESENT IN BLOOD AND PRIMARY AND METASTATIC TUMORS   252
  By: RAO CG, CHIANESE D, DOYLE GV, et al Int J Oncol 27: 49-57, 2005  
17. TUMOR ASSOCIATED MACROPHAGES IN HUMAN PROSTATE CANCER: RELATION TO CLINICOPATHOLOGICAL VARIABLES AND SURVIVAL   252
  By: LISSBRANT IF, STATTIN P, WIKSTROM P, et al Int J Oncol 17: 445-451, 2000  
18. THE HMGA PROTEINS: A MYRIAD OF FUNCTIONS (REVIEW)   244
  By: CLEYNEN I, VAN DE VEN WJM Int J Oncol 32: 289-305, 2008  
19. CIRCULATING microRNAs: NEW BIOMARKERS IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER (REVIEW)   240
  By: ALLEGRA A, ALONCI A, CAMPO S, et al Int J Oncol 41: 1897-1912, 2012  
20. RADIATION-INDUCED AUTOPHAGY IS ASSOCIATED WITH LC3 AND ITS INHIBITION SENSITIZES MALIGNANT GLIOMA CELLS   237
  By: ITO H, DAIDO S, KANZAWA T, et al Int J Oncol 26: 1401-1410, 2005  

Data obtained from the Web of Science Clarivate Analytics 06/05/2021.


We hope that this historical retrospect will be of interest to all readers, and that together, we may look forward to an even more fulfilling future.

Related Articles

Journal Cover

July-2021
Volume 59 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Spandidos DA: EDITORIAL The International Journal of Oncology: 30 years of progress (1992-2021). Int J Oncol 59: 36, 2021
APA
Spandidos, D.A. (2021). EDITORIAL The International Journal of Oncology: 30 years of progress (1992-2021). International Journal of Oncology, 59, 36. https://doi.org/10.3892/ijo.2021.5216
MLA
Spandidos, D. A."EDITORIAL The International Journal of Oncology: 30 years of progress (1992-2021)". International Journal of Oncology 59.1 (2021): 36.
Chicago
Spandidos, D. A."EDITORIAL The International Journal of Oncology: 30 years of progress (1992-2021)". International Journal of Oncology 59, no. 1 (2021): 36. https://doi.org/10.3892/ijo.2021.5216